|
Fusion gene ID: 6409 |
FusionGeneSummary for CDC7_LRRC8C |
Fusion gene summary |
Fusion gene information | Fusion gene name: CDC7_LRRC8C | Fusion gene ID: 6409 | Hgene | Tgene | Gene symbol | CDC7 | LRRC8C | Gene ID | 8317 | 84230 |
Gene name | cell division cycle 7 | leucine rich repeat containing 8 VRAC subunit C | |
Synonyms | CDC7L1|HsCDC7|Hsk1|huCDC7 | AD158|FAD158 | |
Cytomap | 1p22.1 | 1p22.2 | |
Type of gene | protein-coding | protein-coding | |
Description | cell division cycle 7-related protein kinaseCDC7 (cell division cycle 7, S. cerevisiae, homolog)-like 1CDC7-related kinasecell division cycle 7 homologcell division cycle 7-like protein 1 | volume-regulated anion channel subunit LRRC8Cfactor for adipocyte differentiation 158hypothetical protein AD158leucine rich repeat containing 8 family member Cleucine rich repeat containing 8Cleucine-rich repeat-containing protein 8C | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | O00311 | Q8TDW0 | |
Ensembl transtripts involved in fusion gene | ENST00000430031, ENST00000234626, ENST00000428239, ENST00000497611, | ENST00000370454, ENST00000479252, | |
Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 1 X 1 X 1=1 |
# samples | 1 | 1 | |
** MAII score | log2(1/1*10)=3.32192809488736 | log2(1/1*10)=3.32192809488736 | |
Context | PubMed: CDC7 [Title/Abstract] AND LRRC8C [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | STAD | TCGA-VQ-A8E0-01A | CDC7 | chr1 | 91979600 | + | LRRC8C | chr1 | 90184483 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-3UTR | ENST00000430031 | ENST00000370454 | CDC7 | chr1 | 91979600 | + | LRRC8C | chr1 | 90184483 | + |
5CDS-intron | ENST00000430031 | ENST00000479252 | CDC7 | chr1 | 91979600 | + | LRRC8C | chr1 | 90184483 | + |
5CDS-3UTR | ENST00000234626 | ENST00000370454 | CDC7 | chr1 | 91979600 | + | LRRC8C | chr1 | 90184483 | + |
5CDS-intron | ENST00000234626 | ENST00000479252 | CDC7 | chr1 | 91979600 | + | LRRC8C | chr1 | 90184483 | + |
5CDS-3UTR | ENST00000428239 | ENST00000370454 | CDC7 | chr1 | 91979600 | + | LRRC8C | chr1 | 90184483 | + |
5CDS-intron | ENST00000428239 | ENST00000479252 | CDC7 | chr1 | 91979600 | + | LRRC8C | chr1 | 90184483 | + |
intron-3UTR | ENST00000497611 | ENST00000370454 | CDC7 | chr1 | 91979600 | + | LRRC8C | chr1 | 90184483 | + |
intron-intron | ENST00000497611 | ENST00000479252 | CDC7 | chr1 | 91979600 | + | LRRC8C | chr1 | 90184483 | + |
Top |
FusionProtFeatures for CDC7_LRRC8C |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CDC7 | LRRC8C |
Seems to phosphorylate critical substrates that regulatethe G1/S phase transition and/or DNA replication. Canphosphorylates MCM2 and MCM3. {ECO:0000269|PubMed:12065429}. | Non-essential component of the volume-regulated anionchannel (VRAC, also named VSOAC channel), an anion channelrequired to maintain a constant cell volume in response toextracellular or intracellular osmotic changes. The VRAC channelconducts iodide better than chloride and can also conduct organicosmolytes like taurine. Plays a redundant role in the efflux ofamino acids, such as aspartate and glutamate, in response toosmotic stress. Channel activity requires LRRC8A plus at least oneother family member (LRRC8B, LRRC8C, LRRC8D or LRRC8E); channelcharacteristics depend on the precise subunit composition.{ECO:0000269|PubMed:24790029, ECO:0000269|PubMed:26824658,ECO:0000269|PubMed:28193731}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CDC7_LRRC8C |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CDC7_LRRC8C |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
CDC7 | MCM2, MCM7, ORC1, MCM5, ORC6, MCM4, DBF4, MCM3, DBF4B, CHAF1A, CLSPN, RAD18, CDK2, ICK, TOB1, APP, CDC7, MCM6, MCM10, CDKN1A, ORC5, CDKN2A, CDK4, GRHPR, CDK9, GPT, PAF1, CENPJ, XPO1, KMT2E, IFT122, BRD4, RPS11, ING5 | LRRC8C | POPDC2, FCGR3B, LGALS8, ZACN, LRRC8B, HTR3A, FPR2 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CDC7_LRRC8C |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CDC7_LRRC8C |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |